MedTrace Logo

Experimental Therapeutics in Essential Tremor Using Cerebellar Transcranial Direct Current Stimulation

NCT02052271 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2026-04-24

No results posted yet for this study

Summary

The purpose of this study is to determine whether transcranial cathodal direct current stimulation (tDCS) delivered over the cerebellum can improve essential tremor.

Conditions

Interventions

DEVICE

Cathodal cerebellar transcranial direct current active stimulation

Active stimulation: duration: 20 mn, intensity: 2 mA; localisation cerebellum;

DEVICE

Cathodal cerebellar transcranial direct current placebo stimulation

Placebo stimulation: duration: 9 seconds, intensity: 2 mA; localisation cerebellum;

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    lead OTHER_GOV

Principal Investigators

  • Emmanuel Flamand-Roze, MD · Institut du Cerveau et de la Moelle et Fédération de Neurologie de l'Hôpital Pitié-Salpétrière, Paris

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-03
Primary Completion
2018-03-27
Completion
2018-03-27

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02052271 on ClinicalTrials.gov